Dr. Michael Stewart Galloway, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 57 Fairfield Blvd, Crossville, TN 38558 Phone: 931-484-3344 Fax: 931-456-3671 |
Dr. Larry E. Patterson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Iris Ln, Crossville, TN 38555 Phone: 931-456-2728 Fax: 931-456-5446 |
Michael David Patterson, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15 Iris Ln, Crossville, TN 38555 Phone: 931-456-2728 Fax: 931-456-5446 |
David Williamss Litchford, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 33 W Adams St, Crossville, TN 38555 Phone: 931-484-9547 Fax: 931-484-9547 |
News Archive
Santa should share Rudolf's snack of carrots and celery sticks rather than brandy and mince pies and swap his reindeer for a bike or walk, says a public health expert in the Christmas issue published on bmj.com today.
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation treatment called intensity modulated radiotherapy (IMRT), Yale School of Medicine researchers report in the Journal of the National Cancer Institute.
The FDA has approved a software suite developed by Dimensional Dosing Systems, Inc. for determining optimum drug dosages of insulin and many other drugs as well as combinations of drugs.
The Wall Street Journal: "Three leading health-care providers in Colorado's Front Range region recently teamed up in an electronic health-record exchange program that will allow them to share data on more than a million Colorado residents. … The three [health systems] have agreed to share their records on a secure network that will allow clinics, doctors' offices and hospitals to exchange data on common patients instantly, including lab reports, radiology images and medical history" (Landro, 4/13).
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
› Verified 6 days ago